Driving Project Execution Through Bioanalytical Continuity

On this latest episode of The Weekly Bioanalysis podcast, Dom and John dive into one of the most pressing challenges in modern bioanalysis: how to break down silos and drive better project execution through continuity across teams. Drawing from real-world experience, they explore how the industry has evolved from isolated workflows toward more integrated approaches, especially as complex therapeutics like ADCs and emerging platforms push traditional boundaries. The conversation highlights the importance of early collaboration, seamless handoffs between development and validation, and the growing role of cross-functional scientific advisory teams in delivering consistent results. They also touch on emerging trends like microsampling and how innovation is reshaping both preclinical and clinical workflows. It’s a practical, behind-the-scenes look at what it really takes to execute successfully in today’s increasingly complex bioanalytical landscape.“The Weekly Bioanalysis” is a podcast dedicated to discussing bioanalytical news, tools and services related to the pharmaceutical, biopharmaceutical and biomarker industries. Every month, KCAS Bio will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they’ve learned about the bioanalytical world the past couple of weeks. “The Weekly Bioanalysis” is brought to you by KCAS Bio.KCAS Bio is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA, and Lyon, France, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the pharmaceutical, biopharmaceutical, animal health and medical device industries.